Home Featured Page 194

Featured

Latest

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M

MindMed Provides Status Update on IND for Phase 2b Trial of...

PT278 – Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara...

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences...

Two esteemed doctors join CB Therapeutics in its exploration of innovative...

Psychedelic Bulletin: COMPASS’ “Infamous” Psilocybin Patent Challenged; atai Stock Price Tumbles...

MYND Life Sciences Acquires Rights for the Use of Psychedelics to...

PTSF89 – A Macro Dive Into Microdosing

MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult...

COMPASS Selected for Addition to NASDAQ Biotechnology Index

Entheon Biomedical Announces EEG Patent Application & Provides Research Update

1...193194195...301 Page 194 of 301

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M

MindMed Provides Status Update on IND for Phase 2b Trial of...

PT278 – Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara...

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences...

Two esteemed doctors join CB Therapeutics in its exploration of innovative...

Psychedelic Bulletin: COMPASS’ “Infamous” Psilocybin Patent Challenged; atai Stock Price Tumbles...

MYND Life Sciences Acquires Rights for the Use of Psychedelics to...

PTSF89 – A Macro Dive Into Microdosing

MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult...

COMPASS Selected for Addition to NASDAQ Biotechnology Index

Entheon Biomedical Announces EEG Patent Application & Provides Research Update

EDITOR PICKS

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY